Fidelis Animal Health, Inc. Announces Major Label Expansion for Ethiqa XR®

Ethiqa XR, an extended-release buprenorphine, adds captive rodents and laboratory rabbits to label for 72-hour control of post-procedural pain. NORTH BRUNSWICK, N.J., Nov. 5, 2024 /PRNewswire/ — Fidelis Animal Health, Inc. has received notification from the Food and Drug Administration…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.